Agilent Technologies, Inc. (A)
Market Cap | 36.94B |
Revenue (ttm) | 6.50B |
Net Income (ttm) | 1.41B |
Shares Out | 287.33M |
EPS (ttm) | 4.81 |
PE Ratio | 26.71 |
Forward PE | 23.42 |
Dividend | $0.94 (0.73%) |
Ex-Dividend Date | Oct 1, 2024 |
Volume | 1,316,228 |
Open | 125.32 |
Previous Close | 125.69 |
Day's Range | 124.89 - 128.71 |
52-Week Range | 123.48 - 155.35 |
Beta | 1.07 |
Analysts | Buy |
Price Target | 143.07 (+11.28%) |
Earnings Date | Nov 25, 2024 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2023, Agilent Technologies's revenue was $6.83 billion, a decrease of -0.22% compared to the previous year's $6.85 billion. Earnings were $1.24 billion, a decrease of -1.12%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for A stock is "Buy." The 12-month stock price forecast is $143.07, which is an increase of 11.28% from the latest price.
News
Agilent Increases Cash Dividend to 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 24.8 cents per share of common stock, a 5% increase over ...
Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that Adeyemi Adeleye, Ph.D., has received the Agilent 2024 Early Career Professor Award for his contribution t...
Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent
CAMBRIDGE, England--(BUSINESS WIRE)--Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Techno...
Agilent Ranks No. 11 on Fortune's List of Best Workplaces in the World
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company has been named to Fortune's list of Best Workplaces in the World, ranking no. 11 among 25 companie...
Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochond...
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Professor Isabelle Plante at Institut National de la Recherche Scientifique (INRS), and Professor Bangyan...
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity I...
Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent will release financial results for the fourth quarter of fiscal year 2024 on Nov. 25.
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will host an Analyst and Investor Day in New York City on Tuesday, Dec. 17, at 10 a.m. ET. CEO Padraig McDonnell, CFO Bob McMa...
H.I.G. Capital Completes the Sale of BIOVECTRA
MIAMI--(BUSINESS WIRE)-- #Acquisition--H.I.G. Capital sold its portfolio company, BIOVECTRA Inc., to Agilent Technologies, Inc. (NYSE: A) for a purchase price of $925 million.
Agilent Completes Acquisition of BIOVECTRA
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization.
Agilent Announces Cash Dividend of 23.6 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholde...
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of Californ...
Airplane engines are in short supply. The business of fixing older ones is booming
Engine repair shops have swelled to a $58 billion business, according to Alton Aviation Consultancy, and are cash cow for engine makers like GE Aerospace.
Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Agilent Technologies focuses on growing biopharma, PFAS testing, and advanced materials for semiconductors. Recent acquisitions and divestitures show mixed results, with potential for technological en...
These Analysts Boost Their Forecasts On Agilent After Strong Earnings
Agilent Technologies, Inc. A posted better-than-expected third-quarter earnings and issued upbeat fourth-quarter guidance on Wednesday.
Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q3 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Conference Call Participants Operator Ladies and gentlemen, welcome to the Agilent...
Agilent beats quarterly results on strong demand from biotech clients
Agilent Technologies on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies.
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1)...
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass ...
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid ...
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.
Agilent to buy contract drug manufacturer Biovectra for $925 million
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
Agilent to Acquire North American CDMO BIOVECTRA
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent has signed a definitive agreement to acquire BIOVECTRA, a leading contract development and manufacturing organization, for $925 million.
Agilent to Announce Third-Quarter Fiscal Year 2024 Financial Results Aug. 21
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition...